All Categories
 
Categories
Contributors
Tags
cancer screening X
 
   
1 items found in 1 pages
Dr Nora Pashayan - Risk stratification for population based screening: Optimising the benefit-harm tradeoffs
Dr Nora Pashayan Clinical Reader in Applied Health Research, Research Dept of Applied Health Research, UCL Institute of Epidemiology and Health Care Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer detection: the earlier the better? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
693
6/4/2019